Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune A Kroken

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Schizophrenia Research. Cognition|July 14, 2021
Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCTLiss Anda, Erik Johnsen, Rune A Kroken, et al.
BMC Psychiatry|October 2, 2013
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized studyErik Johnsen, Igne Sinkeviciute, Else-Marie Løberg, et al.
Substance Use & Misuse|August 9, 2021
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in PsychosisRenata Alisauskiene, Erik Johnsen, Rolf Gjestad, et al.
Plos One|December 16, 2016
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic ImprovementLiss Anda, Kolbjørn S Brønnick, Erik Johnsen, et al.
Frontiers in Psychiatry|December 6, 2014
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological VulnerabilityElse-Marie Løberg, Siri Helle, Merethe Nygård, et al.
Nordic Journal of Psychiatry|October 1, 2010
Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based studyErik Johnsen, Rolf Gjestad, Rune A Kroken, et al.
Schizophrenia Research and Treatment|February 4, 2014
QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation AntipsychoticsErik Johnsen, Kristina Aanesen, Sanjeevan Sriskandarajah, et al.
Journal of Personality Disorders|November 5, 2019
Borderline Personality Disorder: What Predicts Acute Psychiatric Readmissions?Desiré Furnes, Rolf Gjestad, Lars Mehlum, et al.
Nordic Journal of Psychiatry|May 30, 2019
The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic studyRenata Alisauskiene, Else-Marie Løberg, Rolf Gjestad, et al.
Therapeutic Advances in Psychopharmacology|December 10, 2014
Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategiesRune A Kroken, Eirik Kjelby, Tore Wentzel-Larsen, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Schizophrenia Research. Cognition|July 14, 2021
Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCTLiss Anda, Erik Johnsen, Rune A Kroken, et al.
BMC Psychiatry|October 2, 2013
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized studyErik Johnsen, Igne Sinkeviciute, Else-Marie Løberg, et al.
Substance Use & Misuse|August 9, 2021
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in PsychosisRenata Alisauskiene, Erik Johnsen, Rolf Gjestad, et al.
Plos One|December 16, 2016
The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic ImprovementLiss Anda, Kolbjørn S Brønnick, Erik Johnsen, et al.
Frontiers in Psychiatry|December 6, 2014
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological VulnerabilityElse-Marie Løberg, Siri Helle, Merethe Nygård, et al.
Nordic Journal of Psychiatry|October 1, 2010
Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based studyErik Johnsen, Rolf Gjestad, Rune A Kroken, et al.
Schizophrenia Research and Treatment|February 4, 2014
QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation AntipsychoticsErik Johnsen, Kristina Aanesen, Sanjeevan Sriskandarajah, et al.
Journal of Personality Disorders|November 5, 2019
Borderline Personality Disorder: What Predicts Acute Psychiatric Readmissions?Desiré Furnes, Rolf Gjestad, Lars Mehlum, et al.
Nordic Journal of Psychiatry|May 30, 2019
The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic studyRenata Alisauskiene, Else-Marie Løberg, Rolf Gjestad, et al.
Therapeutic Advances in Psychopharmacology|December 10, 2014
Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategiesRune A Kroken, Eirik Kjelby, Tore Wentzel-Larsen, et al.
Pageof 6